COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care
While many infectious disorders are unknown to most neurologists, COVID-19 is very different. It has impacted neurologists and other health care workers, not only in our professional lives but also through the fear and panic within our own families, colleagues, patients and their families, and even...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Movement Disorder Society
2020-05-01
|
| Series: | Journal of Movement Disorders |
| Subjects: | |
| Online Access: | http://www.e-jmd.org/upload/jmd-20042.pdf |
| _version_ | 1797710758503514112 |
|---|---|
| author | Roongroj Bhidayasiri Sasivimol Virameteekul Jong-Min Kim Pramod Kr. Pal Sun-Ju Chung |
| author_facet | Roongroj Bhidayasiri Sasivimol Virameteekul Jong-Min Kim Pramod Kr. Pal Sun-Ju Chung |
| author_sort | Roongroj Bhidayasiri |
| collection | DOAJ |
| description | While many infectious disorders are unknown to most neurologists, COVID-19 is very different. It has impacted neurologists and other health care workers, not only in our professional lives but also through the fear and panic within our own families, colleagues, patients and their families, and even in the wider public. COVID-19 affects all sorts of individuals, but the elderly with underlying chronic conditions are particularly at risk of severe disease, or even death. Parkinson’s disease (PD) shares a common profile as an age-dependent degenerative disorder, frequently associated with comorbidities, particularly cardiovascular diseases, so PD patients will almost certainly fall into the high-risk group. Therefore, the aim of this review is to explore the risk of COVID-19 in PD based on the susceptibility to severe disease, its impact on PD disease severity, potential long-term sequelae, and difficulties of PD management during this outbreak, where neurologists face various challenges on how we can maintain effective care for PD patients without exposing them, or ourselves, to the risk of infection. It is less than six months since the identification of the original COVID-19 case on New Year’s Eve 2019, so it is still too early to fully understand the natural history of COVID-19 and the evidence on COVID-19-related PD is scant. Though the possibilities presented are speculative, they are theory-based, and supported by prior evidence from other neurotrophic viruses closely related to SARS-CoV-2. Neurologists should be on high alert and vigilant for potential acute and chronic complications when encountering PD patients who are suspected of having COVID-19. |
| first_indexed | 2024-03-12T06:56:56Z |
| format | Article |
| id | doaj.art-3a71c25c49ed486a89acb3c41d0facff |
| institution | Directory Open Access Journal |
| issn | 2005-940X 2093-4939 |
| language | English |
| last_indexed | 2024-03-12T06:56:56Z |
| publishDate | 2020-05-01 |
| publisher | Korean Movement Disorder Society |
| record_format | Article |
| series | Journal of Movement Disorders |
| spelling | doaj.art-3a71c25c49ed486a89acb3c41d0facff2023-09-02T23:58:50ZengKorean Movement Disorder SocietyJournal of Movement Disorders2005-940X2093-49392020-05-0113210511410.14802/jmd.20042283COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient CareRoongroj Bhidayasiri0Sasivimol Virameteekul1Jong-Min Kim2Pramod Kr. Pal3Sun-Ju Chung4 Chulalongkorn Centre of Excellence for Parkinson’s Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand Chulalongkorn Centre of Excellence for Parkinson’s Disease & Related Disorders, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India Department of Neurology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, KoreaWhile many infectious disorders are unknown to most neurologists, COVID-19 is very different. It has impacted neurologists and other health care workers, not only in our professional lives but also through the fear and panic within our own families, colleagues, patients and their families, and even in the wider public. COVID-19 affects all sorts of individuals, but the elderly with underlying chronic conditions are particularly at risk of severe disease, or even death. Parkinson’s disease (PD) shares a common profile as an age-dependent degenerative disorder, frequently associated with comorbidities, particularly cardiovascular diseases, so PD patients will almost certainly fall into the high-risk group. Therefore, the aim of this review is to explore the risk of COVID-19 in PD based on the susceptibility to severe disease, its impact on PD disease severity, potential long-term sequelae, and difficulties of PD management during this outbreak, where neurologists face various challenges on how we can maintain effective care for PD patients without exposing them, or ourselves, to the risk of infection. It is less than six months since the identification of the original COVID-19 case on New Year’s Eve 2019, so it is still too early to fully understand the natural history of COVID-19 and the evidence on COVID-19-related PD is scant. Though the possibilities presented are speculative, they are theory-based, and supported by prior evidence from other neurotrophic viruses closely related to SARS-CoV-2. Neurologists should be on high alert and vigilant for potential acute and chronic complications when encountering PD patients who are suspected of having COVID-19.http://www.e-jmd.org/upload/jmd-20042.pdfcoronaviruspandemiccovid-19parkinson’s diseasesars-cov-19 |
| spellingShingle | Roongroj Bhidayasiri Sasivimol Virameteekul Jong-Min Kim Pramod Kr. Pal Sun-Ju Chung COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care Journal of Movement Disorders coronavirus pandemic covid-19 parkinson’s disease sars-cov-19 |
| title | COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care |
| title_full | COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care |
| title_fullStr | COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care |
| title_full_unstemmed | COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care |
| title_short | COVID-19: An Early Review of Its Global Impact and Considerations for Parkinson’s Disease Patient Care |
| title_sort | covid 19 an early review of its global impact and considerations for parkinson s disease patient care |
| topic | coronavirus pandemic covid-19 parkinson’s disease sars-cov-19 |
| url | http://www.e-jmd.org/upload/jmd-20042.pdf |
| work_keys_str_mv | AT roongrojbhidayasiri covid19anearlyreviewofitsglobalimpactandconsiderationsforparkinsonsdiseasepatientcare AT sasivimolvirameteekul covid19anearlyreviewofitsglobalimpactandconsiderationsforparkinsonsdiseasepatientcare AT jongminkim covid19anearlyreviewofitsglobalimpactandconsiderationsforparkinsonsdiseasepatientcare AT pramodkrpal covid19anearlyreviewofitsglobalimpactandconsiderationsforparkinsonsdiseasepatientcare AT sunjuchung covid19anearlyreviewofitsglobalimpactandconsiderationsforparkinsonsdiseasepatientcare |